Concepedia

Haifeng Zhu

HZ

Statistics

Publications

41

Citations

1.9K

H-Index

25

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sir Run Run Shaw Hospital

Nanjing Medical University

The University of Texas Health Science Center at Houston

Zhejiang University

Haifeng Zhu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, molecular oncology, and oncology.

Publications per year

2002–2025

41

Publications

41

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

Rodabe N. Amaria, Peter A. Prieto, Michael T. Tetzlaff et al. · The Lancet Oncology · 2018 · 290 citations

Medicine, Oncology, Surgery +14

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma

Xian-De Liu, Wen Kong, Christine B. Peterson et al. · Nature Communications · 2020 · 176 citations · Full text

Medicine, Immunology, Oncology +17

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Christopher P. Vellano, Michael G. White, Miles C. Andrews et al. · Nature · 2022 · 130 citations · Full text

Life Sciences, Molecular Biology, Oncology +12

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

Jillian F. Wise, Zuzana Berkova, Rohit Mathur et al. · Blood · 2013 · 94 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Injectable self-healing hydrogel with siRNA delivery property for sustained STING silencing and enhanced therapy of intervertebral disc degeneration

Jiaxin Chen, Haifeng Zhu, Yutao Zhu et al. · Bioactive Materials · 2021 · 87 citations · Full text

Pharmacy, Bioengineering, Molecular Pharmaceutics +17

1–5 of 41